中性粒细胞介导的IV型原体降解在轻度内透视性性结肠炎患者中升高,反映出早期的粘膜破坏
Marta S Alexdottir1, Martin Pehrsson2, Viktor Domislovic3
1Department of Biomarkers and Research, Nordic Bioscience, 2370, Herlev, Denmark. mara@nordicbio.com.
Scientific reports
|January 18, 2024
概括
新的生物标志物C4A3-HNE和C4A4-HNE在炎症性肠病中检测早期肠组织损伤. 这些标记物与C4M相结合,可以监测疾病活动并减少内镜手术.
科学领域:
- 胃肠道学和免疫学
- 生物标志物发现发现
- 细胞外矩阵研究 细胞外矩阵研究
背景情况:
- 炎症性肠病 (IBD) 涉及由中性粒细胞驱动的慢性炎症.
- 肠底膜,表达类型IV原链 (COL4A3,COL4A4),对于恒温至关重要.
- 早期检测组织损伤是必要的,以便及时干预IBD.
研究的目的:
- 开发和验证用于IBD早期肠道组织损伤的新生物标志物.
- 评估人类中性粒细胞弹性酶 (HNE) 降解的 COL4A3 和 COL4A4 的新表位素的实用性.
- 将这些新型生物标记物与矩阵金属蛋白酶 (MMP) 介导的降解标记物 (C4M) 进行比较.
主要方法:
- 开发具有竞争力的ELISAs来量化HNE降解的COL4A3和COL4A4新表位素.
- 在两个独立的观察队列 (n=161和n=100) 中对生物标志物的研究.
- 对与疾病活性和内镜检测结果相关的生物标志物水平的分析.
主要成果:
- 与严重疾病相比,在轻度性结肠炎患者中观察到C4A3-HNE水平升高.
- C4M与疾病活动有很强的相关性.
- C4A3-HNE/C4M的组合显示出轻度和重度内镜疾病之间的优异区别,与疾病活性有负相关性. 在第2组中,C4A4-HNE也出现了类似的趋势.
结论:
- C4A3-HNE和C4A4-HNE显示出IBD早期肠道组织损伤的潜在生物标志物.
- 结合针对不同原链和降解途径的标记物,可以提供关于粘膜损伤的全面信息.
- 这些生物标志物可能有助于监测缓解期的疾病爆发,可能减少频繁内镜检查的需要.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
187
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
187
Peptic Ulcer Disease I: Introduction
171
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
171
Peptic Ulcer Disease II: Pathophysiology
438
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
438
Inflammatory Bowel Disease II: Crohn's Disease
248
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
248
Phases of Wound Repair
6.0K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.0K
Drugs for Treatment of Ulcerative Colitis in IBD
142
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
142


